Universal Security Instruments, Inc. — Form 10-Q Summary
Company-name note: The supplied metadata says Universal Safety Products, Inc., but the filing identifies the registrant as Universal Security Instruments, Inc.
Business context and reporting period
This unaudited quarterly report covers the quarter and nine months ended December 31, 2012, in the company’s fiscal year ending March 31. The company markets and distributes safety and security products, primarily manufactured through its 50%-owned Hong Kong joint venture (JV); it accounts for the JV using the equity method.
Financial results and liquidity
| Metric | Quarter ended Dec. 31, 2012 | Nine months ended Dec. 31, 2012 |
|---|---|---|
| Net sales | $4.75 million | $11.27 million |
| Gross profit / margin | $1.03 million / 21.6% | $3.18 million / 28.2% |
| Operating loss | $388,000 | $1.09 million |
| Net income (loss) | $23,000 | $(558,000) |
| Operating cash flow | Not presented for the quarter | $(527,000) |
Quarterly sales increased 49.2% year over year, led by next-generation carbon monoxide detectors. Gross margin declined from 25.7% to 21.6%, which management attributed to product mix. Quarterly net income fell from $67,000, principally reflecting income tax expense and lower interest income, partly offset by higher sales and JV earnings.
For the nine-month period, sales rose 16.2% year over year, while gross margin increased from 27.8% to 28.2%. The net loss widened from $242,000 to $558,000 as higher selling and promotional costs and the tax valuation allowance outweighed sales growth and JV contributions. Selling, general and administrative plus R&D expenses were $4.27 million, including about $447,000 of advertising and promotion for the new product line.
At December 31, cash was $2.54 million, down from $3.19 million at March 31, 2012. Current assets were $10.34 million and current liabilities $832,000; total assets were $26.44 million. The balance sheet reported a $25,000 long-term obligation. The CIT factoring agreement had a stated maximum of $1 million, with $1 million reported available at quarter-end; the filing does not clearly state an outstanding borrowing balance. Operating activities used $527,000, investing activities provided $56,000, and financing activities used $171,000, mainly for share repurchases.
Material changes and related-party operations
The company reported $462,515 of equity earnings from the JV for the nine months, down from $526,114. The JV’s nine-month sales decreased 2.8% to $16.95 million and net income decreased 24.4% to $1.05 million; its quarterly net income increased 43.4% to $850,000. The company purchased $6.90 million of products from the JV during the nine-month period.
The company repurchased 12,000 shares in December at an average $4.20 per share. Since the program began, it had repurchased 87,128 of the authorized 100,000 shares. Outstanding shares were 2,300,759 at February 13, 2013.
Outlook, risks, contingencies and unusual items
No quantified financial guidance is provided. Management said cash on hand, the factoring facility, JV distributions and credit facilities should provide sufficient liquidity. It cautioned that forward-looking results are subject to risks described in its SEC filings.
A $300,000 valuation allowance was established against deferred tax assets for foreign tax credits management believes likely to expire unused within two fiscal years. A June 2012 shipping accident destroyed one container of goods; the company recorded $64,224 of insurance proceeds above the inventory cost previously recorded, representing only part of an estimated $400,000 of profit on the lost sales. This insurance gain is an unusual, nonrecurring item.
Management stated that pending lawsuits and other legal matters were not expected to have a material adverse effect. The company disclosed product warranties of one to ten years to end users and said claims beyond manufacturers’ one-year coverage had been immaterial. Management concluded disclosure controls were effective and reported no material quarterly change in internal control over financial reporting.
Important facts for investors to verify
- Confirm the registrant’s identity: the filing names Universal Security Instruments, Inc., unlike the supplied company metadata.
- Review the $300,000 deferred-tax-asset valuation allowance, the likelihood of foreign tax-credit expiration, and the effect on future tax provisions.
- Assess the JV’s earnings, margins, cash distributions and the company’s dependence on JV-sourced products.
- Confirm actual usage and terms of the CIT factoring facility; the filing reports availability but does not clearly state an outstanding balance.
- Separate recurring operating performance from the insurance recovery and monitor whether new-product sales can support margins after promotional spending.